Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy

Autor: Mohabati D, van Rijssen TJ, van Dijk EHC, Luyten GPM, Missotten TO, Hoyng CB, Yzer S, Boon CJF

Publikováno v: Clinical Ophthalmology, Vol Volume 12, Pp 1061-1070 (2018)

Danial Mohabati,1,2 Thomas J van Rijssen,1 Elon HC van Dijk,1 Gregorius PM Luyten,1 Tom O Missotten,3 Carel B Hoyng,4 Suzanne Yzer,3 Camiel JF Boon1,5 1Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands; 2Departmen

Externí odkaz: https://doaj.org/article/e75d2c3072144145aa3b6f0371a8d773

Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life

Autor: Breukink MB, Dingemans AJM, den Hollander AI, Keunen JEE, MacLaren RE, Fauser S, Querques G, Hoyng CB, Downes SM, Boon CJF

Publikováno v: Clinical Ophthalmology, Vol Volume 11, Pp 39-46 (2016)

Myrte B Breukink,1,* Alexander JM Dingemans,1,* Anneke I den Hollander,1,2 Jan EE Keunen,1 Robert E MacLaren,3,4 Sascha Fauser,5 Giuseppe Querques,6 Carel B Hoyng,1 Susan M Downes,3,4 Camiel JF Boon1,7 1Department of Ophthalmology, 2Department of Hum

Externí odkaz: https://doaj.org/article/a52fb36a3923447f9ae48fc9a53801ca

Using human-induced pluripotent stem cells for modelling the blood-retinal-barrier on-a-chip

Autor: Gagliardi, G, Feitosa-Afonsso, DM, Arik, YB, Heesterbeek, TJ, Hoyng, CB, van der Meer, AD, den Hollander, AI

Publikováno v: 7th International Symposium on AMD: Age-related Macular Degeneration-Understanding Pathogenetic Mechanisms of Disease; 20190920-20190921; Baden-Baden; DOC19amd31 /20200205/

One of the major hallmarks of age-related macular degeneration (AMD) is the accumulation of protein-lipid deposits, known as ‘drusen’, in the tissues of the outer blood-retinal barrier (BRB). The key cells within the BRB are the retinal pigment e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9db023aac4ac59f0244613c20fb4f19f

Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Diabetic Macular Edema (BRDME): The BRDME Study, a Randomized Trial

Autor: Vader, MJC, Schauwvlieghe, ASME, Verbraak, FD, Dijkman, G, Hooymans, JM, Los, LI, Zwinderman, AH, Peto, T, Hoyng, CB, van Leeuwen, R, Vingerling, Hans, Moll, AC, van Lith-Verhoeven, JJC, Dijkgraaf, MG, Schlingemann, RO

Publikováno v: Ophthalmology Retina, 4, 777-788
Ophthalmology. Retina, 4(8), 777-788. Elsevier
Vader, M J C, Schauwvlieghe, A S M E, Verbraak, F D, Dijkman, G, Hooymans, J M M, Los, L I, Zwinderman, A H, Peto, T, Hoyng, C B, van Leeuwen, R, Vingerling, J R, Moll, A C, van Lith-Verhoeven, J J C, Dijkgraaf, M G W, Schlingemann, R O & Bevacizumab and Ranibizumab in Diabetic Macular Edema Study Group 2020, ' Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Diabetic Macular Edema (BRDME) : The BRDME Study, a Randomized Trial ', Ophthalmology Retina, vol. 4, no. 8, pp. 777-788 . https://doi.org/10.1016/j.oret.2020.02.008
Ophthalmology Retina, 4, 8, pp. 777-788
Ophthalmology Retina, 4(8), 777-788. Elsevier Inc.

Contains fulltext : 225964.pdf (Publisher’s version ) (Open Access) PURPOSE: To generate conclusive evidence regarding the noninferiority of intravitreal bevacizumab compared with ranibizumab in patients with diabetic macular edema (DME). DESIGN: C

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::21d84ae21c4574ca9ed25e7a08a51e62
http://hdl.handle.net/2066/225964

Clinical Characterization of 66 Patients With Congenital Retinal Disease Due to the Deep-Intronic c.2991+11655A > G Mutation in CEP290

Autor: Valkenburg, D, Van Cauwenbergh, C, Lorenz, B, van Genderen, MM, Bertelsen, M, Pott, JWR, Coppieters, F, de Zaeytijd, J, Thiadens, Alberta, Klaver, Caroline, Kroes, HY, van Schooneveld, MJ, Preising, M, Hoyng, CB, Leroy, BP, van den Born, LI, Collin, RWJ

Publikováno v: Investigative ophthalmology & visual science, 59(11), 4384-4391. ASSOC RESEARCH VISION OPHTHALMOLOGY INC
Investigative Ophthalmology & Visual Science, 59(11), 4384-4391. Association for Research in Vision and Ophthalmology Inc.

Purpose: To describe the phenotypic spectrum of retinal disease caused by the c.2991+1655A>G mutation in CEP290 and to compare disease severity between homozygous and compound heterozygous patients. Methods: Medical records were reviewed for best-cor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::429fee8cc61cdf454e20b62f3349544b
https://research.rug.nl/en/publications/f5244a69-f673-4271-b231-e90826dca1a6